A detailed history of Manufacturers Life Insurance Company, The transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 285,555 shares of SWTX stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
285,555
Previous 123,418 131.37%
Holding current value
$10.5 Million
Previous $4.65 Million 96.8%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$32.04 - $42.76 $5.19 Million - $6.93 Million
162,137 Added 131.37%
285,555 $9.15 Million
Q2 2024

Aug 14, 2024

SELL
$36.06 - $47.62 $779,292 - $1.03 Million
-21,611 Reduced 14.9%
123,418 $4.65 Million
Q1 2024

May 14, 2024

BUY
$36.5 - $52.5 $1.3 Million - $1.87 Million
35,645 Added 32.59%
145,029 $7.14 Million
Q4 2023

Feb 13, 2024

BUY
$18.94 - $37.24 $453,461 - $891,600
23,942 Added 28.02%
109,384 $3.99 Million
Q3 2023

Nov 15, 2023

BUY
$23.12 - $31.38 $239,500 - $325,065
10,359 Added 13.8%
85,442 $1.98 Million
Q2 2023

Aug 11, 2023

BUY
$23.15 - $32.71 $936,695 - $1.32 Million
40,462 Added 116.87%
75,083 $1.97 Million
Q1 2023

May 15, 2023

BUY
$24.97 - $34.05 $5,593 - $7,627
224 Added 0.65%
34,845 $896,000
Q4 2022

Aug 11, 2023

BUY
$21.73 - $28.72 $12,712 - $16,801
585 Added 1.72%
34,621 $900,000
Q4 2022

Feb 13, 2023

BUY
$21.73 - $28.72 $12,712 - $16,801
585 Added 1.72%
34,621 $900,000
Q3 2022

Aug 11, 2023

SELL
$24.1 - $39.66 $6,989 - $11,501
-290 Reduced 0.84%
34,036 $971,000
Q3 2022

Nov 03, 2022

SELL
$24.1 - $39.66 $6,989 - $11,501
-290 Reduced 0.84%
34,036 $944,000
Q2 2022

Aug 11, 2023

BUY
$18.36 - $60.07 $118,587 - $387,992
6,459 Added 23.18%
34,326 $845,000
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $118,587 - $387,992
6,459 Added 23.18%
34,326 $862,000
Q1 2022

Aug 11, 2023

SELL
$48.97 - $65.46 $341,712 - $456,779
-6,978 Reduced 20.03%
27,867 $1.57 Million
Q1 2022

May 20, 2022

BUY
$48.97 - $65.46 $617,952 - $826,039
12,619 Added 82.76%
27,867 $1.62 Million
Q4 2021

Feb 16, 2022

SELL
$53.3 - $75.84 $1,492 - $2,123
-28 Reduced 0.18%
15,248 $948,000
Q3 2021

Nov 12, 2021

SELL
$62.66 - $88.26 $95,995 - $135,214
-1,532 Reduced 9.11%
15,276 $969,000
Q2 2021

Aug 12, 2021

BUY
$67.45 - $85.63 $198,370 - $251,837
2,941 Added 21.21%
16,808 $1.39 Million
Q1 2021

May 03, 2021

SELL
$65.1 - $93.59 $49,996 - $71,877
-768 Reduced 5.25%
13,867 $1.02 Million
Q4 2020

Feb 12, 2021

BUY
$48.36 - $77.92 $82,985 - $133,710
1,716 Added 13.28%
14,635 $1.06 Million
Q3 2020

Nov 09, 2020

SELL
$36.14 - $51.99 $7,228 - $10,398
-200 Reduced 1.52%
12,919 $616,000
Q2 2020

Aug 10, 2020

BUY
$22.98 - $48.57 $131,261 - $277,431
5,712 Added 77.12%
13,119 $551,000
Q1 2020

May 15, 2020

BUY
$20.44 - $41.21 $151,399 - $305,242
7,407 New
7,407 $200,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.3B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.